Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2021
Drug-Wide Association Study (DWAS): Challenges and OpportunitiesYoujin Wang, Shahinaz M GadallaBlood Reviews|July 19, 2011
Telomere biology in hematopoiesis and stem cell transplantationShahinaz M Gadalla, Sharon A SavagePrimary Care|July 21, 2009
Cancer risk assessment for the primary care physicianLarissa A Korde, Shahinaz M GadallaInternational Journal of Cancer|November 17, 2017
Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly womenCatherine Schairer, Ruth M Pfeiffer, Shahinaz M GadallaProgress in Molecular Biology and Translational Science|July 5, 2014
Telomeres in molecular epidemiology studiesClara Bodelon, Sharon A Savage, Shahinaz M GadallaJournal of the National Cancer Institute|October 2, 2018
The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the LiteratureLisa Gallicchio, Shahinaz M Gadalla, John D Murphy, et al.Breast Cancer Research and Treatment|February 17, 2018
Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare populationCatherine Schairer, D Michal Freedman, Shahinaz M Gadalla, et al.Aging|November 30, 2010
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromesShahinaz M Gadalla, Richard Cawthon, Neelam Giri, et al.Statistical Methods in Medical Research|October 9, 2018
Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophyDavid B Wolfson, Ana F Best, Vittorio Addona, et al.Journal of the Neurological Sciences|October 16, 2025
A novel discovery of elevated risk of neuroendocrine tumors in patients with myotonic dystrophyBilal Hameed, Muzzammil Ahmadzada, Timothy S McNeel, et al.Pageof 13